Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Yellow Pea Protein and Fibre and Short Term Food Intake

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01255085
Recruitment Status : Completed
First Posted : December 7, 2010
Last Update Posted : June 15, 2012
Sponsor:
Collaborator:
Agriculture and Agri-Food Canada
Information provided by (Responsible Party):
G. Harvey Anderson, University of Toronto

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
It is hypothesized that yellow pea protein and fiber will reduce short-term food intake, subjective appetite and glycemic response.

Condition or disease Intervention/treatment Phase
Obesity Type II Diabetes Mellitus Metabolic Syndrome Dietary Supplement: yellow pea protein Dietary Supplement: yellow pea fiber Dietary Supplement: Control Tomato Soup Not Applicable

Detailed Description:
A within-subject, randomized study was conducted. Each subject returned 5 times, 1 week apart, and received 1 of the 5 treatments per week. The 5 treatments were tomato soup with 10 or 20 g of isolated yellow pea fibre or protein, or a control soup with no added pea fractions. Food intake was measured at an ad libitum pizza meal served 30 minutes after treatment. Satiety and blood glucose (via finger prick) were measured throughout the treatment period.
Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 20 participants
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Single (Participant)
Primary Purpose: Prevention
Official Title: The Effect of Yellow Pea Protein and Fiber on Short Term Food Intake, Subjective Appetite and Glycemic Response in Healthy Young Males
Study Start Date : May 2008
Actual Primary Completion Date : August 2010
Actual Study Completion Date : June 2011

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Dietary Fiber

Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Experimental: 10 g of yellow pea fiber Dietary Supplement: yellow pea fiber
Served in a tomato soup
Experimental: 20 g of yellow pea fiber Dietary Supplement: yellow pea fiber
Served in a tomato soup
Experimental: 10 g of yellow pea protein Dietary Supplement: yellow pea protein
Served in a tomato soup
Experimental: 20 g of yellow pea protein Dietary Supplement: yellow pea protein
Served in a tomato soup
Experimental: Control Tomato Soup Dietary Supplement: Control Tomato Soup
Served in a tomato soup


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Energy Intake [ Time Frame: at 30 minutes after treatment ]
    Energy intake at an ad libitum pizza meal


Secondary Outcome Measures :
  1. Glycemic Response [ Time Frame: 0-170 minutes post treatment ]
    Blood Glucose every 15-30 minutes via finger prick

  2. Subjective Appetite [ Time Frame: 0-170 minutes post treatment ]
    Subjective Appetite measured every 15-30 minutes via Visual Analog Scale (VAS)


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   20 Years to 29 Years   (Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • male 20-30 years old healthy weight

Exclusion Criteria:

  • smoking restrictive eating metabolic diseases breakfast skippers dieters
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01255085


Locations
Layout table for location information
Canada, Ontario
University of Toronto - Department of Nutritional Sciences
Toronto, Ontario, Canada, M5S 3E2
Sponsors and Collaborators
University of Toronto
Agriculture and Agri-Food Canada
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: G. Harvey Anderson, Professor, University of Toronto
ClinicalTrials.gov Identifier: NCT01255085    
Other Study ID Numbers: PureNet_22627
First Posted: December 7, 2010    Key Record Dates
Last Update Posted: June 15, 2012
Last Verified: June 2012
Keywords provided by G. Harvey Anderson, University of Toronto:
Obesity
Food intake regulation
blood glucose regulation
protein
 fiber
pulses
yellow peas
Additional relevant MeSH terms:
Layout table for MeSH terms
Metabolic Syndrome
Diabetes Mellitus, Type 2
Insulin Resistance
Hyperinsulinism
 Glucose Metabolism Disorders
Metabolic Diseases
Diabetes Mellitus
Endocrine System Diseases